Products

Pharmaceutical CAS 192725 -17-0 Lopinavir Powder Raw Material Lopinavir Purity Lopinavir
Pharmaceutical CAS 192725 -17-0 Lopinavir Powder Raw Material Lopinavir Purity Lopinavir

Pharmaceutical CAS 192725 -17-0 Lopinavir Powder Raw Material Lopinavir Purity Lopinavir

China Pharmaceutical CAS 192725-17-0 Lopinavir Powder Raw Material Lopinavir Purity Lopinavir, Find details about China Lopinavir, Lopinavir Ritonavir from Pharmaceutical CAS 192725-17-0 Lopinavir Powder Raw Material Lopinavir Purity Lopinavir

Model NO.
D-sung Lopinavir
Product Name
Lopinavir
Name
Lopinavir Powder
Appearance
White Powder
Color
White
Grade
Pharmaceutical Grade
Assay
HPLC 99%
Application
Anti-Aids;Treatment HIV
Specific
COA
Test Method
HPLC
Shelf Life
2 Years
CAS No.
192725-17-0
Mf
C37h48n4o5
MW
628.814
Melting Point
124-127°c
Density
1.163
Trademark
D-sung
Transport Package
Negotiable
Specification
99%
Origin
Shaanxi Xi′an
Model NO.
D-sung Lopinavir
Product Name
Lopinavir
Name
Lopinavir Powder
Appearance
White Powder
Color
White
Grade
Pharmaceutical Grade
Assay
HPLC 99%
Application
Anti-Aids;Treatment HIV
Specific
COA
Test Method
HPLC
Shelf Life
2 Years
CAS No.
192725-17-0
Mf
C37h48n4o5
MW
628.814
Melting Point
124-127°c
Density
1.163
Trademark
D-sung
Transport Package
Negotiable
Specification
99%
Origin
Shaanxi Xi′an
Pharmaceutical CAS 192725-17-0 Lopinavir Powder Raw Material Lopinavir Purity Lopinavir
Pharmaceutical CAS 192725-17-0 Lopinavir  Powder Raw Material Lopinavir Purity Lopinavir
Product Description
Pharmaceutical CAS 192725-17-0 Lopinavir Powder Raw Material Lopinavir Purity LopinavirPharmaceutical CAS 192725-17-0 Lopinavir Powder Raw Material Lopinavir Purity Lopinavir
Product Details
Pharmaceutical CAS 192725-17-0 Lopinavir Powder Raw Material Lopinavir Purity Lopinavir
Product nameLopinavir
Cas number192725-17-0
ApperanceWhite powder
MFC37H48N4O5
MW628.814
Lopinavir is a potent HIV protease inhibitor with Ki of 1.3 pM.Target: HIV proteaseLopinavir is a potent inhibitor of Rh123 efflux in Caco-2 monolayers with IC50 of 1.7 mM. Lopinavir exposure (72 hours) in LS 180V cells reduces the content of intracellular Rh123. Lopinavir induces P-glycoprotein immunoreactive protein and messenger RNA levels in LS 180V cells. Lopinavir inhibits subtype C clone C6 with IC50 of 9.4 nM. Lopinavir inhibits CYP3A with IC50 of 7.3 mM in human liver microsomes, while produces negligible or weak inhibition of human CYP1A2, 2B6, 2C9, 2C19 and 2D6. Lopinavir (10 mg/kg, orally) results in Cmax of 0.8 μg/mL and oral bioavailability of 25% in rats.
Application&Function
Pharmaceutical CAS 192725-17-0 Lopinavir Powder Raw Material Lopinavir Purity LopinavirLopinavir is an antiretroviral of the protease inhibitor class. Inhibition of HIV-1 protease prevents cleavage of the viral polyprotein precursor and results in the release of immature, noninfectious virions. A component of combination therapy to treat HIV/AIDS.
Specification
Pharmaceutical CAS 192725-17-0 Lopinavir Powder Raw Material Lopinavir Purity LopinavirPharmaceutical CAS 192725-17-0 Lopinavir Powder Raw Material Lopinavir Purity LopinavirPharmaceutical CAS 192725-17-0 Lopinavir Powder Raw Material Lopinavir Purity Lopinavir
Pharmaceutical CAS 192725-17-0 Lopinavir Powder Raw Material Lopinavir Purity LopinavirPharmaceutical CAS 192725-17-0 Lopinavir Powder Raw Material Lopinavir Purity LopinavirPharmaceutical CAS 192725-17-0 Lopinavir Powder Raw Material Lopinavir Purity Lopinavir
Pharmaceutical CAS 192725-17-0 Lopinavir Powder Raw Material Lopinavir Purity Lopinavir
 
 

You Might Also Like